Healthcare and Spine Leader Discussed Allogeneic Cell Innovations as Part of Global Regenerative Medicine Event
Marietta, GA (PRWEB) December 13, 2016
Scott P. Bruder, M.D., Ph.D., Chairman of the parent company of Amendia, Inc., spoke at the World Stem Cell Summit on December 8 at the Palm Beach County Convention Center in West Palm Beach, Florida.
Dr. Bruder’s presentation was titled “Our Journey from Autologous to Allogeneic Stem Cell Therapy: How did we get here & when do we use what?” and was delivered in collaboration with three other leading experts as part of the event’s cell therapy program.
The World Stem Cell Summit & RegMed Capital Conference is the original, translation-focused global meeting of industry stakeholders. Now in its 12th year, and with over 1,200 attendees, 225 speakers, and 90-plus hours of programming, the World Stem Cell Summit serves as the choice venue for forging collaborations with worldwide pioneers across multiple disciplines.
“This summit is the premier opportunity to illuminate and explore the business of regenerative medicine on a worldwide scale,” said Dr. Bruder. “My presentation on allogeneic cells with Timothy Ganey, Ph.D., Lou Barnes, and Lisa Ferrara, Ph.D. is one of several important and distinguished cell-manufacturing discussions that focus on translation and commercialization for the present and future of stem cell medicine.”
Over the course of his 25-year career in healthcare, Dr. Bruder has united principles from basic science, clinical medicine, and industrial development to deliver products that enhance patients’ lives and improve outcomes. As a veteran physician, scientist, and executive, he now leads Bruder Consulting International, LLC, providing a variety of services to medical device, biotechnology, and regenerative medicine entities. Currently, he serves as Chairman of the Board of Directors of the parent company of Amendia, Inc., helping to develop biologic implants and medical devices for spine applications.
“Dr. Bruder’s command of the business of regenerative medicine, and influence in healthcare as a whole, is invaluable to the present and future of Amendia’s spine device and biologics innovation,” said Amendia CEO Chris Fair. “We’re honored to have such an insightful luminary on our team.”
About Regenerative Medicine Foundation
The World Stem Cell Summit is a project of the nonprofit Regenerative Medicine Foundation. Since 2003, Regenerative Medicine Foundation and its predecessor Genetics Policy Institute have built the strongest, most comprehensive and trusted global network of Regenerative Medicine stakeholders, uniting the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies and patient organizations. Our mission is to accelerate regenerative medicine to improve health and deliver cures. We are committed to the ethical advancement of innovative medicine powered by regenerative, restorative, and curative technologies. Learn more at http://www.regmedfoundation.org.
About 2016 WSCS
The World Stem Cell Summit is the “window to the world” to stem cell research and regenerative medicine. It is the original, translation-focused global meeting of stakeholders, now celebrating its 12th year. With 1,200+ attendees, 225+ speakers and 90+ hours of programming it is no surprise that attendees travel from 30+ countries in order to attend. WSCS16 is organized by the Center for the Advancement of Science in Space (CASIS), the sole manager of the International Space Station U.S. National Laboratory; Centre For Commercialization Of Regenerative Medicine (Canada); Diabetes Research Institute Foundation; Kyoto University Institute for Integrated Cell Material Science; Mayo Clinic; NOVA Southeastern University Cell Therapy Institute; The Cure Alliance; University of Miami Miller School of Medicine ISCI (Interdisciplinary Stem Cell Institute); and Wake Forest School of Medicine Institute for Regenerative Medicine. Learn more at http://www.worldstemcellsummit.com.
For more information on the World Stem Cell Summit & RegMed Capital Conference, and Dr. Bruder’s presentation, visit the event website.
Headquartered in a state-of-the-art manufacturing facility in Marietta, GA, Amendia is a leading designer, developer, manufacturer and marketer of medical devices used in spinal surgical procedures. Amendia’s mission is to exceed surgeon and patient expectations by creating balanced solutions with disruptive technologies for medical devices paired with biologics and instrumentation. Amendia’s vertically-integrated strategy focuses on improving surgical outcomes and the lives of patients with spinal disorders. For more information, please visit http://www.amendia.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/amendia/world-stem-cell-summit/prweb13920472.htm